Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CASIC Builder™ was developed as a result of research conducted through an NIH project SBIR. Initially focused on adherence assessments for individuals living with HIV, the program has since broadened its scope to evaluate factors related to depression, substance and alcohol abuse, as well as sexual risk behaviors. Currently, it serves as a robust and user-friendly tool for creating questionnaires, managing research studies, and facilitating clinical applications. The software's capacity to inquire about a patient's medication regimen has made it valuable in studies concerning adherence to heart medications and opioid prescriptions. Its adaptability has also enabled its utilization in a Brazilian research project that required sign language videos for participants who are deaf. CASIC Builder™ can be accessed with or without its specialized medication components. Since its launch over a decade ago, we have aimed to create a browser-based platform that is effective for complex studies and diverse patient groups while ensuring a straightforward user experience. This commitment to accessibility and flexibility continues to drive enhancements in the software's capabilities.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
$795 one-time payment
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
West Portal Software
Country
United States
Website
www.westportal.com
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Product Features
Survey
Custom Survey URLs
Data Analysis Tools
Email Marketing
Mobile Survey
Offline Response Collection
Paper Survey
Question Branching
Question Library
Site Intercept Survey
Skip Logic
Supports Audio / Images / Video